BusinessFDA & Industry Veteran Brian E. Harvey, MD, PhD, Joins Thetis Pharmaceuticals as Senior Medical DirectorBy Nasdaq OMXMay 7, 2018, 4:27 PM UTC
BusinessAtlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD PouchitisBy Nasdaq OMXMay 2, 2018, 12:02 PM UTC
BusinessLyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel DiseaseBy Nasdaq OMXApr 23, 2018, 7:18 PM UTC
BusinessRegentys, Cook Biotech to Collaborate in Developing, Delivering Unique Ulcerative Colitis TreatmentBy Nasdaq OMXFeb 14, 2018, 12:00 PM UTC
BusinessLyfebulb Partners with UnitedHealth Group to Support Patient-Driven Innovations for People with Inflammatory Bowel DiseaseBy Nasdaq OMXJan 17, 2018, 1:02 PM UTC
BusinessRegentys Names Dr. John F. Howes Vice President of Clinical and Regulatory AffairsBy Nasdaq OMXJan 9, 2018, 12:31 PM UTC
BusinessThetis Builds Scientific Advisory Board to Guide Development of Immuno-Resolving Therapies for IBDBy Nasdaq OMXDec 11, 2017, 3:35 PM UTC
